The board of directors of EMS Ltd. approved on Thursday a proposal to raise funds of up to Rs 400 crore at a face value of Rs 10 per share through a qualified institutional placement. The company will raise the funds in one or more tranches, subject to approval from the shareholders, according to an exchange filing.
Earlier, in a conversation with NDTV Profit, Ashish Tomar, managing director of the firm, highlighted that the company is on track to maintain margins in the range of 24–25% in the current financial year despite diversification.
"For FY25, revenue is going to grow by somewhat around 30–35% over the previous year. The overall margins, percentage wise, will remain in the same range as the previous year," Tomar said.
Shares of EMS closed 8.09% higher at Rs 815.40 apiece in the BSE, compared to a 0.29% rise in the benchmark Sensex. The stock has risen 191.98% in the last 12 months and 92.57% on a year-to-date basis on the NSE.
RECOMMENDED FOR YOU
Nestle India Share Price Advances As Board Approves 1:1 Bonus
Jun 26, 2025
Indogulf Cropsciences IPO: Anchor Investors Invest Rs 58 Crore
Jun 25, 2025
 Syngene is a subsidiary of Biocon Ltd..jpg?rect=0%2C0%2C3500%2C1969&w=75)
Biocon Shares Trade Higher After Board Sets Floor Price For Rs 4,500-Crore QIP
Jun 17, 2025
Reliance Industries Sells Asian Paints Shares Worth Rs 7,703 Crore, SBI Mutual Fund Sole Buyer
Jun 12, 2025
POPULAR